The University of Utah College of Pharmacy's Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health (NIH) to ...

Researchers from Lund University in Sweden have discovered higher levels of immune proteins in the blood before and after an epileptic seizure. The possible biomarkers can be identified using a simple ...

Takeda’s late-phase epilepsy program has failed a key test, chalking up misses on the primary endpoints in pivotal trials in two indications. But the Japanese drugmaker still plans to talk to ...

Doctors are testing a promising experimental treatment using stem cells to combat seizures in patients with epilepsy. NBC News’ Dr. Akshay Syal spoke with a trial patient about her experience.

AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...

Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham Heart Study show those who scored ...

NEW HAVEN, Conn. (KABC) -- Every state has different requirements when it comes to driving with epilepsy. Here in California, patients must be seizure-free for a specific period of time and submit a ...

A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is investigating how advanced brain monitoring could improve the diagnosis and management ...

Oregon paramedics will start testing a drug that could some day let people treat long, dangerous seizures even before an ambulance arrives. If the test works, it could give a new anti-seizure tool not ...